Ticker >

Kopran share price

Kopran Ltd.

NSE: KOPRAN BSE: 524280 SECTOR: Pharmaceuticals & Drugs  35k   120   24

226.75
+0.05 (0.02%)
NSE: 29 Sep 03:53 PM

Price Summary

Today's High

₹ 230

Today's Low

₹ 223.1

52 Week High

₹ 253

52 Week Low

₹ 96

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1093.18 Cr.

Enterprise Value

1118.47 Cr.

No. of Shares

4.82 Cr.

P/E

39.6

P/B

2.76

Face Value

₹ 10

Div. Yield

1.33 %

Book Value (TTM)

₹  82.09

CASH

2.59 Cr.

DEBT

27.88 Cr.

Promoter Holding

44.49 %

EPS (TTM)

₹  5.73

Sales Growth

33.53%

ROE

8.07 %

ROCE

9.44%

Profit Growth

166.11 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year33.53%
3 Year15.06%
5 Year12.18%

Profit Growth

1 Year166.11%
3 Year40.7%
5 Year46.03%

ROE%

1 Year8.07%
3 Year7.23%
5 Year6.56%

ROCE %

1 Year9.44%
3 Year9.55%
5 Year9.06%

Debt/Equity

0.0705

Price to Cash Flow

64.81

Interest Cover Ratio

14.8170827562975

CFO/PAT (5 Yr. Avg.)

0.547628397025376

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2023 44.49 0
Mar 2023 44.3 0
Dec 2022 44.3 0
Sep 2022 44.25 0
Jun 2022 44.25 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 15.0582769729654% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 14.8170827562975.
  • Company’s PEG ratio is 0.238414466368621.
  • The company has an efficient Cash Conversion Cycle of 47.5363376465841 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.93431516632419.

 Limitations

  • Company has a poor ROE of 7.22622142276535% over the past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023
Net Sales 71.18 53.62 67.96 80.23 65.86
Total Expenditure 64.7 47.72 61.86 72.87 65.04
Operating Profit 6.48 5.91 6.1 7.36 0.82
Other Income 0.17 14.74 1.16 2.07 1.48
Interest 0.5 0.61 0.72 0.84 0.95
Depreciation 1.08 1.12 1.12 1.09 1.12
Exceptional Items 0 0 0 0 0
Profit Before Tax 5.08 18.91 5.42 7.51 0.23
Tax 1.28 1.02 1.38 1.99 0.07
Profit After Tax 3.8 17.89 4.04 5.52 0.15
Adjusted EPS (Rs) 0.79 3.71 0.84 1.14 0.03

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 196.65 179.29 222.83 204.52 273.09
Total Expenditure 173.95 156.11 192.68 189.26 245.18
Operating Profit 22.7 23.18 30.15 15.26 27.91
Other Income 3.22 1.99 10.46 8.18 16.09
Interest 5.46 5.96 3.81 2.95 2.67
Depreciation 3.11 3.47 4.1 4.32 4.41
Exceptional Items 0 0 0 0 0
Profit Before Tax 17.36 15.73 32.71 16.16 36.92
Tax 4.39 4.51 9.23 4.42 5.66
Net Profit 12.97 11.22 23.47 11.74 31.25
Adjusted EPS (Rs.) 3 2.59 5.43 2.44 6.48

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 43.25 43.25 43.25 48.21 48.21
Total Reserves 175.19 186.42 203.6 330.51 347.38
Borrowings 21.71 9.67 2.36 2.08 2.3
Other N/C liabilities 0.65 2.64 6.17 7.07 7.18
Current liabilities 74.81 83.87 68.57 76.25 100.88
Total Liabilities 315.61 325.85 323.95 464.12 505.95
Assets
Net Block 41.88 42.95 47.44 46.22 47.35
Capital WIP 0.94 0.94 0 0 0
Intangible WIP 5.82 6.13 2.82 3.1 3.53
Investments 157.52 158.14 158.79 259.43 260.07
Loans & Advances 1.93 3.38 3.74 3.92 4.1
Other N/C Assets 0.11 0.08 0.04 0.14 0.49
Current Assets 107.42 114.23 111.12 151.31 190.41
Total Assets 315.61 325.85 323.95 464.12 505.95
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 17.36 15.73 32.71 16.16 36.92
Adjustment 3.32 11.64 7.38 4.17 -9.04
Changes in Assets & Liabilities -4.9 -13.53 14.1 -54.53 -4.68
Tax Paid -3.94 -3.87 -5.41 -3.61 -6.32
Operating Cash Flow 11.84 9.97 48.77 -37.8 16.87
Investing Cash Flow -4.47 0.63 -8.51 -100.26 10.05
Financing Cash Flow -7.43 -10.6 -40.14 137.99 -26.13
Net Cash Flow -0.06 0 0.12 -0.07 0.79

Corporate Actions

Investors Details

PARTICULARS Jun 2022% Sep 2022% Dec 2022% Mar 2023% Jun 2023%
promoters 44.25 44.25 44.30 44.30 44.49
g.claridge & company limi... 0.71 0.71 0.71 0.71 0.71
hazarimall somani - - 0.04 0.04 0.04
hridai susheel somani - 0.24 0.24 0.24 0.24
jaya somani 0.54 0.54 0.54 0.54 0.54
kopran lifestyle limited - - 0.01 0.01 0.01
mr adarsh somani - - 0.38 0.38 0.38
mridula somani 0.47 0.47 0.47 1.04 1.64
nupur somani - 0.56 0.56 0.56 0.56
oricon enterprises ltd - - 12.90 12.90 12.90
panorama finvest pvt ltd - - 7.88 7.88 7.88
parijat shipping and fina... 0.80 0.80 0.80 0.80 0.80
rajendra somani 4.82 4.82 4.82 4.26 3.66
sarvamangal mercantile co... - - 6.02 6.02 6.02
somani kumkum 0.07 0.07 0.07 0.07 0.07
suhrid somani 0.19 0.19 0.19 0.19 0.19
surendra somani 1.04 1.04 1.04 1.04 1.24
susheel somani 1.81 1.81 1.81 1.81 1.81
united shippers ltd 4.56 4.56 4.56 4.56 4.56
vandana somani 0.67 0.67 0.67 0.67 0.67
varun somani 0.57 0.57 0.57 0.57 0.57
adarsh somani 0.38 0.38 - - -
kopran lifestyle ltd 0.01 0.01 - - -
oricon enterprises ltd. 12.90 12.90 - - -
panorama finvest pvt.ltd.... 7.88 7.88 - - -
sarvamangal mercantile co... 6.02 6.02 - - -
hridai shusheel somani 0.24 - - - -
nupur somani 0.56 - - - -
PARTICULARS Jun 2022% Sep 2022% Dec 2022% Mar 2023% Jun 2023%
investors 55.75 55.75 55.70 55.70 55.51
laxminarayan vyapaar p lt... 1.96 1.96 1.96 1.96 1.95
madhuri madhusudan kela - - - - 1.04
viraj russell mehta 1.85 1.85 1.85 1.85 1.85
madhuri madhusudan kela .... - - - 1.04 -
ashutosh taparia 1.37 1.33 1.02 - -
mahima stocks private lim... 1.04 1.04 1.04 - -

Annual Reports

Ratings & Research Reports

Company Presentations

  • PresentationQ4FY22 21 Jun 2022
  • PresentationQ4FY21 11 Jun 2021
  • PresentationQ3FY21 20 May 2021
  • PresentationQ2FY21 9 Nov 2020

Company News

Kopran informs about closure of trading window26 Sep 2023, 4:48PM Kopran informs about loss of share certificate22 Sep 2023, 5:22PM Kopran informs about details of loss of certificate 11 Sep 2023, 4:39PM Kopran - Quaterly Results10 Aug 2023, 12:51PM Kopran - Quaterly Results10 Aug 2023, 12:51PM Kopran - Quaterly Results10 Aug 2023, 12:51PM Kopran - Quaterly Results25 May 2023, 3:15PM Kopran - Quaterly Results25 May 2023, 3:15PM Kopran - Quaterly Results25 May 2023, 3:15PM Kopran informs about PCS certificate21 Apr 2023, 4:37PM Kopran informs about details of loss of certificate23 Feb 2023, 4:50PM Kopran informs about issuance of duplicate share certificates18 Feb 2023, 10:58AM Kopran informs about newspaper publication13 Feb 2023, 5:09PM Kopran - Quaterly Results10 Feb 2023, 2:15PM Kopran - Quaterly Results10 Feb 2023, 2:15PM Kopran - Quaterly Results10 Feb 2023, 2:15PM Kopran informs about details of loss of certificate24 Jan 2023, 4:44PM Kopran informs about details of loss of certificate3 Jan 2023, 5:01PM Kopran informs about loss of share certificate13 Dec 2022, 2:20PM Kopran informs about details of loss of certificate 7 Dec 2022, 3:40PM Kopran - Quaterly Results11 Nov 2022, 4:49PM Kopran - Quaterly Results11 Nov 2022, 4:49PM Kopran informs about board meeting 1 Nov 2022, 4:46PM Kopran - Quaterly Results10 Aug 2022, 1:31PM Kopran - Quaterly Results10 Aug 2022, 1:31PM Kopran - Quaterly Results10 Aug 2022, 1:31PM Kopran submits annual report6 Aug 2022, 2:42PM Kopran informs about certificate 13 Jul 2022, 4:57PM Kopran informs about loss of share certificates29 Jun 2022, 5:03PM Kopran informs about loss of share certificate24 Jun 2022, 4:36PM Kopran - Quaterly Results27 May 2022, 3:37PM Kopran - Quaterly Results27 May 2022, 3:37PM Kopran informs about board meeting13 May 2022, 3:55PM Kopran informs about issuance of duplicate share certificate23 Apr 2022, 11:55AM Kopran informs about certificate7 Apr 2022, 4:15PM Kopran informs about loss of share certificate10 Mar 2022, 3:07PM Kopran informs about loss of share certificate8 Mar 2022, 5:05PM Kopran informs about loss of share certificate23 Feb 2022, 11:29AM Kopran informs about newspaper advertisement19 Feb 2022, 2:36PM Kopran - Quaterly Results3 Feb 2022, 1:38PM Kopran - Quaterly Results3 Feb 2022, 1:38PM Kopran - Quaterly Results3 Feb 2022, 1:38PM Kopran’s arm gets process patent for API product13 Dec 2021, 10:56AM Kopran informs about closure of trading window3 Dec 2021, 4:40PM Kopran informs about issue of securities3 Dec 2021, 4:39PM Kopran informs about loss of share certificate5 Oct 2021, 3:30PM Kopran submits annual report2 Aug 2021, 3:09PM Kopran informs about updates29 Jul 2021, 12:19PM Kopran informs about book closure12 Jul 2021, 5:21PM Kopran informs about presentation11 Jun 2021, 2:07PM

Kopran Stock Price Analysis and Quick Research Report. Is Kopran an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Kopran and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 16.868 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Kopran has a Debt to Equity ratio of 0.0705 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Kopran , the EPS growth was 166.11658456486 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Kopran has OPM of 10.2210294740142 % which is a bad sign for profitability.
     
  • ROE: Kopran have a poor ROE of 8.07242055996916 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Last Updated on:
Brief about Kopran
X